A drug that in theory should have killed a cancer patient instead seemed to have halted or even reversed her disease.
For the first time since a rare cancer appeared eight years before, her lymph nodes had shrunk to a normal size, her skin was no longer bright red and inflamed, and the itchiness that plagued her had subsided.
Mrs. McDaniel, the 69-year-old wife of a retired corporate executive, had gambled on the ultimate in personalized medicine, an approach known as whole genome sequencing, and it seemed to be paying off.
See on www.nytimes.com
Latest posts by Tom George (see all)
- New Digital Trends In Today’s Smartphone-Obsessed World - September 6, 2016
- 5 Things a Recruiter Looks for in a Resume - August 30, 2016
- Obtaining Legal Immunity for Pet Cohabitation - August 30, 2016